Exhibit 10.5
NONCOMPETITION AND NONSOLICITATION
AGREEMENT
This
Noncompetition and Nonsolicitation Agreement (this
“Agreement”) is dated as of the 7th day of March, 2007
(the “Effective Date”) by and between Lawrence
Mastrovich (the “Executive”) and Apria Healthcare Group
Inc. (the “Company”).
INTRODUCTORY PROVISIONS
The
following provisions are true and correct and constitute the basis
for this Agreement:
|
A.
|
Concurrently herewith, the
Executive is entering into one or more agreements (herein referred
to as “Incentive Compensation Agreements”) with the
Company pursuant to which the Executive, subject to continued
employment through the dates therein described and certain other
restrictions, is receiving the option to purchase and/or otherwise
receive shares of common stock issued by the Company as well as
certain other benefits and the Executive is now being or may
hereafter be offered the opportunity, at the Company’s
discretion, to participate in one or incentive compensation or
similar plans pursuant to which the Executive will be eligible to
earn additional compensation beyond the Executive’s base
salary (hereinafter referred to as “Incentive Compensation
Plans”).
|
|
B.
|
The Executive and the Company are
executing this document to express their agreement concerning
certain covenants pertaining to the protection of the
Company’s confidential information and trade secrets and its
business whereby the Executive agrees to satisfy certain
obligations to perform and refrain from performing certain acts
during the Executive’s employment with the Company and
following the termination of the Executive’s employment with
the Company.
|
|
C.
|
The Executive and the Company
acknowledge and agree that the rights granted to the Executive
under the Incentive Compensation Plans and Incentive Compensation
Agreements, as well as the Executive’s continued at-will
employment with the Company and access to the Company’s
confidential information and trade secrets, Executive’s
continued receipt of salary and other remuneration and benefits
associated with that at-will employment, and other good and
valuable consideration, constitute adequate and sufficient
consideration for the Executive’s entering into this
Agreement.
|
NOW, THEREFORE, for the purposes and considerations
expressed above, the parties hereto, intending to be legally bound,
agree as follows:
1. Confidential Information
.
|
|
(a)
The Executive acknowledges that, in
the performance of the Executive’s duties on behalf of the
Company, the Executive has had and will have access to, has
received and will receive, and has been entrusted and will be
entrusted with confidential information and trade secrets including
but not limited to systems technology, field operations,
reimbursement, development, marketing, organizational, financial,
management, administrative, clinical, customer, distribution and
sales information, data, specifications and processes owned by the
Company or any of its affiliates (collectively, the “Company
Group”), or used presently or at any time in the future in
the course of the business of the Company Group that is not
otherwise part of the public domain (collectively, the
“Confidential Material”). All such Confidential
Material is considered secret and was and will be made available to
the Executive in confidence.
|
|
|
(b)
The Executive hereby agrees that the
Executive shall not at any time (whether during or after the
Executive’s employment with the Company), directly or
indirectly, other than in the course of the Executive’s
duties for the Company, disclose or make available to any person,
firm, corporation, association or other entity for any reason or
purpose whatsoever, any Confidential Material; provided, however,
that this Section 1(b) shall not apply (i) when disclosure is
required by law or by any court, arbitrator, mediator or
administrative or legislative body (including any committee
thereof) with apparent jurisdiction to order the Executive to
disclose or make available such information (provided, however,
that the Executive shall promptly notify the Company in writing
upon receiving a request for such information), or (ii) with
respect to any other litigation, arbitration or mediation involving
this Agreement, including but not limited to enforcement of this
Agreement. The Executive agrees that, upon termination of the
Executive’s employment with the Company, all Confidential
Material in the Executive’s possession that is in written,
digital or other tangible form (together with all copies or
duplicates thereof, including computer files) shall be returned to
the Company and shall not be retained by the Executive or furnished
to any third party, in any form except as provided herein;
provided, however, that the Executive shall not be obligated to
treat as confidential, or return to the Company copies of any
Confidential Material that (x) was publicly known at the time of
disclosure to the Executive, (y) becomes publicly known or
available thereafter other than by any means in violation of this
Agreement or any other duty owed to the Company by any person or
entity, or (z) is lawfully disclosed to the Executive by a third
party.
|
2. Noncompetition Covenants
.
|
|
(a) The Executive
acknowledges that the Executive’s employment with a
competitor of the Company Group within a reasonable time following
the termination of the Executive’s employment with the
Company Group would create a substantial likelihood that the
Executive would inevitably disclose or use, to the detriment of the
Company Group, Confidential Material, and that it is essential to
the Company Group’s legitimate business interests and also to
free and fair competition in the industry within which the Company
Group does business, to protect the Company Group’s
Confidential Material from disclosure.
|
|
|
(b) The risk of
inevitable disclosure is particularly applicable to any such
employment by the Executive with those competitors of the Company
Group that are similar in operation, service, missions and markets
to the Company Group (“Principal Competitors”). As of
the date of this Agreement, the Principal Competitors are: Lincare
Holdings, Inc.; Rotech Healthcare, Inc.; American HomePatient,
Inc.; Coram Healthcare Corporation; Option Care, Inc.; Pacific
Pulmonary Services Corporation; LifeCare Solutions, Inc.; and the
home healthcare businesses of Air Products & Chemicals, Inc.
and Praxair, Inc. and their respective parent, affiliated and
subsidiary companies.
|
|
|
(c) In order avoid
the disclosure by the Executive of the Company’s trade
secrets or other Confidential Material to those businesses that
could most adversely affect the performance of the Company Group
and damage its goodwill, the Executive agrees that, during the
period of the Executive’s employment by the Company and for a
period of one year following the date on which the
Executive’s employment with the Company Group terminates for
any reason (the “Post-Termination Period”), the
Executive will not engage, directly or indirectly, in business with
or work with or for, whether as an owner, employee, consultant or
otherwise, any Principal Competitor; provided, however, that this
restriction shall not prevent the Executive from owning less than
1% of any class of publicly-traded securities (or other equity
interests held through a publicly-traded mutual fund or similar
investment) of a Principal Competitor following the termination of
the Executive’s employment with the Company. The Executive
expressly acknowledges and agrees that the foregoing restriction is
reasonable and necessary in order to protect the Confidential
Material of the Company Group. The phrase “engage, directly
or indirectly” means engaging or having an interest in,
directly or indirectly, as owner, partner, participant of a joint
venture, trustee, proprietor, shareholder, member, manager,
director, officer, employee, independent contractor, capital
investor, lender, consultant, advisor or similar
capacity.
|
3. Nonsolicitation Covenants
.
|
|
(a) During the
term of the Executive’s employment with the Company and
during the Post-Termination Period, the Executive will not,
directly or indirectly, individually or as a consultant to, or as
an employee, officer, stockholder, director or other owner or
participant in any business, influence or attempt to influence
customers, patients, referral sources, vendors, suppliers,
licensors, lessors, joint venturers, associates, consultants,
agents, or partners of the Company Group, either directly or
indirectly, to divert their business away from the Company Group,
to any individual, partnership, firm, corporation or other entity
then in competition with the business of any entity within the
Company Group, and the Executive will not otherwise interfere with,
disrupt or attempt to disrupt the business relationships,
contractual or otherwise, between the Company, any of its
respective affiliates or subsidiaries, and any customers,
suppliers, vendors, lessors, licensors, joint venturers,
associates, officers, employees, consultants, managers, partners,
members of or investors in any entity within the Company
Group.
|
|
|
(b) During the
term of the Executive’s employment with the Company and
during the Post-Termination Period, the Executive will not on
behalf of any individual or entity (other than the Company Group)
directly or indirectly (i) induce, encourage or otherwise solicit
(or assist in soliciting) any person who is an employee,
independent contractor, consultant or business partner of any
entity within the Company Group to terminate his, her or its
employment relationship, contract, consulting relationship or
partnership arrangement with such entity to accept any other
employment or position; or (ii) assist any other entity in hiring
any such employee, independent contractor, consultant or business
partner.
|
4. Cooperation; Nondisparagement .
The Executive agrees that, following termination of employment with
the Company, the Executive will cooperate, at no financial cost to
the Executive, with any reasonable request the Company may make for
information or assistance with respect to any matter involving the
Executive. Furthermore, the Executive shall at no time make any
libelous or slanderous remarks or writings about any entity within
the Company Group, or any such entity’s officers or
directors.
5. Company Remedies . In the event
that the Company, acting in good faith and based on its reasonable
belief at the time, determines that the Executive has engaged in
Detrimental Activity, the Company shall have the right to take any
or all of the actions set forth in this Section 5 to the fullest
extent not prohibited by law; provided, however, that in the case
of Detrimental Activity described in clause (i) of the definition
of
|